wp-plugin-hostgator
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114ol-scrapes
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114Source: https:\/\/www.theverge.com\/2022\/8\/4\/23292267\/monkeypox-home-testing-saliva-lesions-covid<\/a> After two years of COVID-19, the conversation around monkeypox testing gives off an unnerving sense of deja-vu. The similarities are right there: painful swabs, the struggle to even find a test, bottlenecks, and a long wait for results. But the diseases are different enough that experience with COVID-19 didn\u2019t give researchers much of a leg up in their efforts to improve the monkeypox testing process. <\/p>\n In the early days of the COVID-19 pandemic, experts bemoaned the lack of investment<\/a> in rapid, at-home testing for various diseases in the United States. The thought was that if the infrastructure had been in place before the coronavirus emerged, it would have been easier to scale up testing \u2014 and maybe help control the pandemic. Eventually, that scale-up happened anyway. Money and resources flooded into testing projects, and soon, at-home COVID-19 tests became ubiquitous. That experience was supposed to<\/a> set the stage for a future with easy access to home tests for any number of diseases once they popped onto the scene. <\/p>\n Against that backdrop, it would seem that monkeypox might offer a perfect test case. It\u2019s an unfamiliar disease spreading rapidly, and there\u2019s high demand for tests. But monkeypox isn\u2019t the best benchmark for whether that future is going to materialize, says Ben Pinsky, the medical co-director for point of care testing at Stanford Health Care. \u201cIt\u2019s a different enough infection,\u201d he says. <\/p>\n
\n
<\/br><\/code><\/p>\n